相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Alternative lengthening of telomeres, ATRX loss and H3-K27M mutations in histologically defined pilocytic astrocytoma with anaplasia
Fausto J. Rodriguez et al.
BRAIN PATHOLOGY (2019)
Primary intracranial sarcomas with DICER1 mutation often contain prominent eosinophilic cytoplasmic globules and can occur in the setting of neurofibromatosis type 1
Julieann C. Lee et al.
ACTA NEUROPATHOLOGICA (2019)
The molecular landscape of glioma in patients with Neurofibromatosis 1
Fulvio D'Angelo et al.
NATURE MEDICINE (2019)
Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations
Annekathrin Reinhardt et al.
ACTA NEUROPATHOLOGICA (2018)
Subependymal giant cell astrocytoma-like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type-1-association
Doreen N. Palsgrove et al.
MODERN PATHOLOGY (2018)
Neurofibromin knockdown in glioma cell lines is associated with changes in cytokine and chemokine secretion in vitro
Matthew D. Wood et al.
SCIENTIFIC REPORTS (2018)
Effects of methylphenidate on cognition and behaviour in children with neurofibromatosis type 1: a study protocol for a randomised placebo-controlled crossover trial
Natalie A. Pride et al.
BMJ OPEN (2018)
Phenotypic expression of a spectrum of Neurofibromatosis Type 1 (NF1) mutations identified through NGS and MLPA
Maria Tsipi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)
Glioblastoma in neurofibromatosis 1 patients without IDH1, BRAF V600E, and TERT promoter mutations
Ichiyo Shibahara et al.
BRAIN TUMOR PATHOLOGY (2018)
Characterization of early communicative behavior in mouse models of neurofibromatosis type 1
Susan E. Maloney et al.
AUTISM RESEARCH (2018)
A porcine model of neurofibromatosis type 1 that mimics the human disease
Katherine A. White et al.
JCI INSIGHT (2018)
Estrogen activation of microglia underlies the sexually dimorphic differences in Nf1 optic glioma-induced retinal pathology
Joseph A. Toonen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Sensitization of Ion Channels Contributes to Central and Peripheral Dysfunction in Neurofibromatosis Type 1
Aubin Moutal et al.
MOLECULAR NEUROBIOLOGY (2017)
Epilepsy in neurofibromatosis type 1
Anthony Pecoraro et al.
EPILEPSY & BEHAVIOR (2017)
Hippocampal sclerosis and associated focal cortical dysplasia-related epilepsy in neurofibromatosis type I
Jordan Gales et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2017)
CNS Tumors in Neurofibromatosis
Jian Campian et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas
Susan Byrne et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study
Anuradha Banerjee et al.
NEURO-ONCOLOGY (2017)
The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas
A. Pemov et al.
ONCOGENE (2017)
Neurofibromatosis type 1 is not associated with subarachnoid haemorrhage
Arttu Kurtelius et al.
PLOS ONE (2017)
The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation
Anne C. Solga et al.
ONCOTARGET (2017)
Epilepsy Mechanisms in Neurocutaneous Disorders: Tuberous Sclerosis Complex, Neurofibromatosis Type 1, and Sturge-Weber Syndrome
Carl E. Stafstrom et al.
FRONTIERS IN NEUROLOGY (2017)
Neurofibromatosis type 1
David H. Gutmann et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
A phase II prospective study of selumetinib in children with recurrent or refractory low-grade glioma (LGG): A Pediatric Brain Tumor Consortium (PBTC) study.
Jason R. Fangusaro et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
The NF1 somatic mutational landscape in sporadic human cancers
Charlotte Philpott et al.
HUMAN GENOMICS (2017)
Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 1
D. Gareth R. Evans et al.
CLINICAL CANCER RESEARCH (2017)
Connections between constitutional mismatch repair deficiency syndrome and neurofibromatosis type 1
K. Wimmer et al.
CLINICAL GENETICS (2017)
Increased Risk of Cerebrovascular Disease Among Patients With Neurofibromatosis Type 1 Population-Based Approach
Anna R. Terry et al.
STROKE (2016)
Frequent alternative lengthening of telomeres and ATRX loss in adult NF1-associated diffuse and high-grade astrocytomas
Fausto J. Rodriguez et al.
ACTA NEUROPATHOLOGICA (2016)
Histologically Benign, Clinically Aggressive: Progressive Non-Optic Pathway Pilocytic Astrocytomas in Adults with NF1
Roy E. Strowd et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2016)
Neurofibromatosis type 1 associated low grade gliomas: A comparison with sporadic low grade gliomas
Jelte Helfferich et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Nf1+/- monocytes/macrophages induce neointima formation via CCR2 activation
Waylan K. Bessler et al.
HUMAN MOLECULAR GENETICS (2016)
NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1
Joseph A. Toonen et al.
HUMAN MOLECULAR GENETICS (2016)
Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis
Jaishri O. Blakeley et al.
NEURO-ONCOLOGY (2016)
Neurocognitive outcomes in neurofibromatosis clinical trials Recommendations for the domain of attention
Karin S. Walsh et al.
NEUROLOGY (2016)
Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas
Eva Dombi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Case Report: A Rosette-forming Glioneuronal Tumor in the Tectal Plate in a Patient with Neurofibromatosis Type I
Emily P. Sieg et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2016)
Pilocytic astrocytoma: pathology, molecular mechanisms and markers
V. Peter Collins et al.
ACTA NEUROPATHOLOGICA (2015)
Cerebellar Hypoplasia and Dysmorphia in Neurofibromatosis Type 1
Sandra P. Toelle et al.
CEREBELLUM (2015)
Differences in the clinical courses of pediatric and adult pilocytic astrocytomas with progression: a single-institution study
Hyang-Hwa Ryu et al.
CHILDS NERVOUS SYSTEM (2015)
Clinicopathologic implications of NF1 gene alterations in diffuse gliomas
M. Adelita Vizcaino et al.
HUMAN PATHOLOGY (2015)
Incidence and Mortality of Neurofibromatosis: A Total Population Study in Finland
Elina Uusitalo et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Ras-Mek-Erk Signaling Regulates Nf1 Heterozygous Neointima Formation
Brian K. Stansfield et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1
Kelly A. Diggs-Andrews et al.
ANNALS OF NEUROLOGY (2014)
Neuronal NF1/RAS regulation of cyclic AMP requires atypical PKC activation
Corina Anastasaki et al.
HUMAN MOLECULAR GENETICS (2014)
Histopathologic Features of Intracranial Vascular Involvement in Fibromuscular Dysplasia, Ehlers-Danlos Type IV, and Neurofibromatosis I
Seth Lummus et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2014)
The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial
Laurence Lion-Francois et al.
ORPHANET JOURNAL OF RARE DISEASES (2014)
Modulation of cAMP and Ras Signaling Pathways Improves Distinct Behavioral Deficits in a Zebrafish Model of Neurofibromatosis Type 1
Marc A. Wolman et al.
CELL REPORTS (2014)
Handheld Optical Coherence Tomography During Sedation in Young Children With Optic Pathway Gliomas
Robert A. Avery et al.
JAMA OPHTHALMOLOGY (2014)
Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice
Kelly A. Diggs-Andrews et al.
ANNALS OF NEUROLOGY (2013)
Reduced microglial CX3CR1 expression delays neurofibromatosis-1 glioma formation
Winnie W. Pong et al.
ANNALS OF NEUROLOGY (2013)
Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1
Karin S. Walsh et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2013)
Epilepsy surgery in Neurofibromatosis Type 1
Carmen Barba et al.
EPILEPSY RESEARCH (2013)
NF1 Molecular Characterization and Neurofibromatosis Type I Genotype-Phenotype Correlation: The French Experience
Audrey Sabbagh et al.
HUMAN MUTATION (2013)
MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors
Walter J. Jessen et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Pilocytic astrocytomas of the optic nerve and their relation to pilocytic astrocytomas elsewhere in the central nervous system
Gerald F. Reis et al.
MODERN PATHOLOGY (2013)
Functional outcome measures for NF1-associated optic pathway glioma clinical trials
Michael J. Fisher et al.
NEUROLOGY (2013)
Neurofibromatosis Type 1 and Autism Spectrum Disorder
Shruti Garg et al.
PEDIATRICS (2013)
Sensitivity of Glioblastomas to Clinically Available MEK Inhibitors Is Defined by Neurofibromin 1 Deficiency
Wendy L. See et al.
CANCER RESEARCH (2012)
MAPK pathway activation in pilocytic astrocytoma
David T. W. Jones et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
Zebrafish neurofibromatosis type 1 genes have redundant functions in tumorigenesis and embryonic development
Jimann Shin et al.
DISEASE MODELS & MECHANISMS (2012)
Rosette-forming glioneuronal tumour of the lateral ventricle in a patient with neurofibromatosis 1
S. Kemp et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2012)
BRAF Duplications and MAPK Pathway Activation Are Frequent in Gliomas of the Optic Nerve Proper
Fausto J. Rodriguez et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
Neurofibromatosis-1 heterozygosity impairs CNS neuronal morphology in a cAMP/PKA/ROCK-dependent manner
Jacquelyn A. Brown et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2012)
Choroidal Abnormalities Detected by Near-Infrared Reflectance Imaging as a New Diagnostic Criterion for Neurofibromatosis 1
Francesco Viola et al.
OPHTHALMOLOGY (2012)
Alterations in White Matter Microstructure in Neurofibromatosis-1
Katherine H. Karlsgodt et al.
PLOS ONE (2012)
Loss of NF1 Expression in Human Endothelial Cells Promotes Autonomous Proliferation and Altered Vascular Morphogenesis
Anshika Bajaj et al.
PLOS ONE (2012)
PI3K/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytoma
Erika F. Rodriguez et al.
ACTA NEUROPATHOLOGICA (2011)
PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice
Jacquelyn A. Brown et al.
EXPERIMENTAL NEUROLOGY (2011)
OLIG2 is differentially expressed in pediatric astrocytic and in ependymal neoplasms
Jose Javier Otero et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Neurofibromatosis-1 Heterozygosity Increases Microglia in a Spatially and Temporally Restricted Pattern Relevant to Mouse Optic Glioma Formation and Growth
Grant W. Simmons et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
Epileptic seizures in neurofibromatosis type 1 are related to intracranial tumors but not to neurofibromatosis bright objects
Hsiang-Yao Hsieh et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2011)
The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
Michelle C. Mendoza et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
Longitudinal Study of Vision and Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis
Lauren S. Talman et al.
ANNALS OF NEUROLOGY (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Cyclic AMP Suppression Is Sufficient to Induce Gliomagenesis in a Mouse Model of Neurofibromatosis-1
Nicole M. Warrington et al.
CANCER RESEARCH (2010)
Genetic variants promoting smooth muscle cell proliferation can result in diffuse and diverse vascular diseases: Evidence for a hyperplastic vasculomyopathy
Dianna M. Milewicz et al.
GENETICS IN MEDICINE (2010)
Oligodendrocyte progenitor cell numbers and migration are regulated by the zebrafish orthologs of the NF1 tumor suppressor gene
Jeong-Soo Lee et al.
HUMAN MOLECULAR GENETICS (2010)
A Distinct Set of Drosophila Brain Neurons Required for Neurofibromatosis Type 1-Dependent Learning and Memory
Monica E. Buchanan et al.
JOURNAL OF NEUROSCIENCE (2010)
Neurofibromin regulates corticostriatal inhibitory networks during working memory performance
Carrie Shilyansky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Cerebrovascular dysplasia in neurofibromatosis type 1
A. G. Cairns et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Gliomas in neurofibromatosis type 1: A clinicopathologic study of 100 patients
Fausto J. Rodriguez et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Neurofibromatosis-1 regulates neuronal and glial cell differentiation from neuroglial progenitors in vivo by both cAMP- and ras-dependent mechanisms
Balazs Hegedus et al.
CELL STEM CELL (2007)
Vascular abnormalities in patients with neurofibromatosis syndrome type 1: Clinical spectrum, management, and results
Gustavo S. Oderich et al.
JOURNAL OF VASCULAR SURGERY (2007)
Distinct functional domains of neurofibromatosis type 1 regulate immediate versus long-term memory formation
Ivan Shun Ho et al.
JOURNAL OF NEUROSCIENCE (2007)
Moyamoya following cranial irradiation for primary brain tumors in children
N. J. Ullrich et al.
NEUROLOGY (2007)
Optic pathway gliomas in neurofibromatosis-1: Controversies and recommendations
Robert Listernick et al.
ANNALS OF NEUROLOGY (2007)
Neurofibromin is a novel regulator of RAS-induced signals in primary vascular smooth muscle cells
Fang Li et al.
HUMAN MOLECULAR GENETICS (2006)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation
Y Zhu et al.
DEVELOPMENT (2005)
The nature and frequency of cognitive deficits in children with neurofibromatosis type 1
SL Hyman et al.
NEUROLOGY (2005)
Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma
Y Zhu et al.
CANCER CELL (2005)
Microglia function in brain tumors
JJ Watters et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Brain apparent diffusion coefficient evaluation in pediatric patients with neurofibromatosis type 1
G Tognini et al.
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY (2005)
Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors
B Dasgupta et al.
CANCER RESEARCH (2005)
Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1
TL Rosser et al.
NEUROLOGY (2005)
Late-onset optic pathway tumors in children with neurofibromatosis 1
R Listernick et al.
NEUROLOGY (2004)
Aberrant growth and differentiation of oligodendrocyte progenitors in neurofibromatosis type 1 mutants
MR Bennett et al.
JOURNAL OF NEUROSCIENCE (2003)
Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1)
JS Guillamo et al.
BRAIN (2003)
Targeting ras signalling pathways in cancer therapy
J Downward
NATURE REVIEWS CANCER (2003)
Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1)
DH Gutmann et al.
NEUROLOGY (2002)
Cardiovascular disease in neurofibromatosis 1: Report of the NF1 cardiovascular task force
JM Friedman et al.
GENETICS IN MEDICINE (2002)
GTPase activating proteins: critical regulators of intracellular signaling
S Donovan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2002)
Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1
RM Costa et al.
NATURE (2002)
Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain
Y Zhu et al.
GENES & DEVELOPMENT (2001)
Insights into the pathogenesis of neurofibromatosis 1 vasculopathy
SJ Hamilton et al.
CLINICAL GENETICS (2000)
Loss of neurofibromin is associated with activation of Ras/MAPK and PI3-K/Akt signaling in a neurofibromatosis 1 astrocytoma
N Lau et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2000)
分享论文
